Jinxin Fertility, the assisted reproduction services division of China’s Jinxin Group that is backed by several private equity investors, has filed for an IPO in Hong Kong.
Jinxin Fertility was founded in 2003 with a single in-vitro fertility (IVF) facility in Chengdu, and now operates four clinics in China – three owned by the company and one under a joint management agreement...
Investors see opportunity in bringing a promising currency exchange-focused fintech model from Europe into Southeast Asia. Singapore-focused YouTrip is the region’s first mover in this niche
Traditionally the overlooked, underappreciated or misrepresented facet of ESG, governance is gaining prominence in emerging markets private equity as investors reassess risk exposure
Capital has poured into China’s online education sector in recent years, but with losses mounting and valuations called into question, investors are finding that not all business models are created equal
Endiya Partners, an early-stage VC investor based in India, has achieved a first close of $40 million for its second fund. The target is $70 million.